These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32332017)

  • 1. Radiological Patterns of Drug-induced Interstitial Lung Disease (DILD) in Early-phase Oncology Clinical Trials.
    Terbuch A; Tiu C; Candilejo IM; Scaranti M; Curcean A; Bar D; Estevez Timon M; Ameratunga M; Ang JE; Ratoff J; Minchom AR; Banerji U; de Bono JS; Tunariu N; Lopez JS
    Clin Cancer Res; 2020 Sep; 26(18):4805-4813. PubMed ID: 32332017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug induced interstitial lung disease in oncology phase I trials.
    Yonemori K; Hirakawa A; Kawachi A; Kinoshita F; Okuma H; Nishikawa T; Tamura K; Fujiwara Y; Takebe N
    Cancer Sci; 2016 Dec; 107(12):1830-1836. PubMed ID: 27685762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prognostic factors in severe drug-induced interstitial lung disease caused by antineoplastic drug therapy in the real world.
    Kaku S; Horinouchi H; Watanabe H; Yonemori K; Okusaka T; Boku N; Yamazaki N; Kawai A; Ohe Y; Kusumoto M
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1737-1746. PubMed ID: 35129672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of and risk factors for interstitial lung disease induced by chemotherapy for lung cancer.
    Sakurada T; Kakiuchi S; Tajima S; Horinouchi Y; Okada N; Nishisako H; Nakamura T; Teraoka K; Kawazoe K; Yanagawa H; Nishioka Y; Minakuchi K; Ishizawa K
    Ann Pharmacother; 2015 Apr; 49(4):398-404. PubMed ID: 25565405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug-induced interstitial lung diseases: often forgotten].
    Poschenrieder F; Stroszczynski C; Hamer OW
    Radiologe; 2014 Dec; 54(12):1180-8. PubMed ID: 25446693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expert consensus on the diagnosis and treatment of anticancer drug-induced interstitial lung disease].
    Anticancer Drug-induced Interstitial Lung Disease Management Group
    Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):693-702. PubMed ID: 35880334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of Time-to-onset of Interstitial Lung Disease after the Administration of Small Molecule Molecularly-targeted Drugs].
    Komada F
    Yakugaku Zasshi; 2018; 138(2):229-235. PubMed ID: 29386436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of drug-induced interstitial lung disease in hospitalised patients: a nested case-control study.
    Jo T; Michihata N; Yamana H; Morita K; Ishimaru M; Yamauchi Y; Hasegawa W; Urushiyama H; Uda K; Matsui H; Fushimi K; Yasunaga H; Nagase T
    Thorax; 2021 Dec; 76(12):1193-1199. PubMed ID: 33888574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease.
    Saito K; Gemma A; Tatsumi K; Hattori N; Ushiki A; Tsushima K; Saito Y; Abe M; Horimasu Y; Kashiwada T; Mori K; Sato M; Nishiya T; Takamatsu K; Sun Y; Arakawa N; Izumi T; Ohno Y; Saito Y; Hanaoka M
    Sci Rep; 2022 Nov; 12(1):19819. PubMed ID: 36396675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of DILD in molecular targeted therapies.
    Saito Y; Gemma A
    Int J Clin Oncol; 2012 Dec; 17(6):534-41. PubMed ID: 23152005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Risk Factors for Side Effects and the Establishment of Supportive Therapy during Cancer Chemotherapy].
    Sakurada T
    Yakugaku Zasshi; 2018; 138(11):1363-1370. PubMed ID: 30381644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interstitial lung disease associated with chemotherapy and molecularly-targeted drug: diagnosis and management].
    Saito Y; Gemma A
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2531-7. PubMed ID: 22189216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of kynurenine and quinolinic acid as promising serum biomarkers for drug-induced interstitial lung diseases.
    Sun Y; Saito K; Ushiki A; Abe M; Saito Y; Kashiwada T; Horimasu Y; Gemma A; Tatsumi K; Hattori N; Tsushima K; Takemoto K; Ishikawa R; Momiyama T; Matsuyama SI; Arakawa N; Akane H; Toyoda T; Ogawa K; Sato M; Takamatsu K; Mori K; Nishiya T; Izumi T; Ohno Y; Saito Y; Hanaoka M
    Respir Res; 2024 Jan; 25(1):31. PubMed ID: 38221627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced lung disease: a brief update for radiologists.
    Ufuk F; Bayraktaroğlu S; Rüksan Ütebey A
    Diagn Interv Radiol; 2023 Jan; 29(1):80-90. PubMed ID: 36960496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug-induced interstitial lung disease].
    Gemma A
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1668-70. PubMed ID: 18931568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis.
    Huang A; Xu Y; Zang X; Wu C; Gao J; Sun X; Xie M; Ma X; Deng H; Song J; Ren F; Pang L; Qian J; Yu Z; Wan S; Chen Y; Pan L; Zhuang G; Liu S; Xue X
    BMC Cancer; 2021 May; 21(1):634. PubMed ID: 34051746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of Time-to-onset and Onset-pattern of Interstitial Lung Disease after the Administration of Monoclonal Antibody Agents].
    Komada F; Nakayama Y; Takara K
    Yakugaku Zasshi; 2018; 138(12):1587-1594. PubMed ID: 30504674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of 12 cases of antineoplastic agents-induced interstitial lung disease.
    Li X; Gu YL; Liu XC; Sun ZX; Sun Y
    Front Pharmacol; 2023; 14():1218480. PubMed ID: 37701034
    [No Abstract]   [Full Text] [Related]  

  • 19. Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease.
    Dai HP; Ma F; Ren YH; Chen SS; Li YQ
    Curr Med Sci; 2023 Feb; 43(1):1-12. PubMed ID: 36867358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced Interstitial Lung Disease Has the Same Degree of Risk for Mortality as Old Age in Patients With Lung Cancer.
    Iwashita K; Mizuno T; Kumazawa S; Imaizumi K; Yamada S
    Anticancer Res; 2021 Mar; 41(3):1707-1711. PubMed ID: 33788769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.